Amrinone in the treatment of chronic cardiac failure
- 26 May 1984
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 3 (5) , 1282-1290
- https://doi.org/10.1016/s0735-1097(84)80189-8
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failureThe American Journal of Cardiology, 1983
- Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure.Circulation, 1981
- Amrinone and exercise performance in patients with chronic heart failureThe American Journal of Cardiology, 1981
- Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators.Circulation, 1980
- Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failureThe American Journal of Cardiology, 1980
- Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].Circulation Research, 1979
- Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.Circulation, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Circulation, 1977
- The role of vasodilator therapy in heart failureProgress in Cardiovascular Diseases, 1977